Who we are

Who we are

Passionate about change, passionate about making a difference

Rear view of employee looking at laptop screen
Man taking notes on laptop and notebook

Our team

We put people at the heart of our business, valuing the wellbeing and rewarding the contributions and commitment of our team. For us, healthy and supported staff are key to our collective success.

With a friendly, supportive working environment that encourages creativity and fresh ideas, our people have the opportunity to learn from each other and shine together… and that doesn’t benefit just us, but makes a real difference for our clients too.

Our values

Be the change you want to see in the world. It’s a well-known phrase, but it’s one we’re all in agreement with. We truly believe in leading by example and working with integrity, guided by a set of values that we all – as a team – helped to shape.

Passion, inclusivity, accountability… these are just a few of the things we stand for, but there’s much more that makes us proud to be Alpharmaxim.

Birds eye view of employee taking notes
Two team members in a meeting

Our vacancies

We’re always looking to grow our team and welcome talented, passionate and creative people to our Alpharmaxim family.

Talk to us about how we can transform your communications

Talk to us about how we can transform your communications

Why Plain Language Summaries are vital in rare disease communications

Why Plain Language Summaries are vital in rare disease communications

Plain language summaries can translate complex science for different audiences. But what are they, and how do they improve awareness?
What can COVID-19 campaigns tell us about increasing vaccine uptake?

What can COVID-19 campaigns tell us about increasing vaccine uptake?

We examine what lessons we can take from the COVID-19 vaccine campaigns, and how behavioural science insights may help to drive vaccine uptake.
Transforming the rare disease landscape

Transforming the rare disease landscape

Over the coming months, we’ll be looking at how new, tailored approaches to communications could help transform the rare disease landscape.